Audit of the Drug Enforcement Administration's Confidential Source Policies and Oversight of Higher-Risk Confidential Sources
- NARA ID
- audit-drug-enforcement-administrations-confidential-source-policies-and-oversight-higher
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Audit
- Released
- 2015-07-21
- Slug
- doj-oig-audit-drug-enforcement-administrations-confidential-source-policies-and-oversight-higher
- Indexed
- 2026-04-27 05:07:11
More from DOJ OIG — Drug Enforcement Administration
- Audit of the Drug Enforcement Administration’s El Paso Intelligence Center Seizure System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2024
- Investigative Summary: Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct
- Audit of the Drug Enforcement Administration's Adoptive Seizure Process and Status of Related Equitable Sharing Requests
- Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- Audit of the Drug Enforcement Administration's Aviation Division Office Internet System Pursuant to the Federal Information Security Modernization Act of 2014 Fiscal Year 2018
Browse all 59 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.